MedPath

MORPHINE EXTRA-FORTE

MORPHINE EXTRA-FORTE

Discontinued
DIN Number

00869325

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00869325
AIG Number0104545006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular ,  Intravenous ,  Subcutaneous
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MORPHINE SULFATEActive
Strength: 50 MG / ML
Monograph: MORPHINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.